Company
News and press
As a thought leader in the technology space, GATC Health is committed to remaining at the forefront of innovation. Here’s our latest happenings, updates, and industry recognition.
GATC Health Featured in BioSpace: AI’s Growing Role in De-Risking Drug Development
August 12, 2026 — GATC Health was featured in a new BioSpace article exploring how AI is transforming the economics of drug development an…
Drug Target Review Features the Science Behind GATC’s New Addiction Drug Candidate
July 23, 2026 — A new feature in Drug Target Review explores the science and data behind GATC Health’s discovery of a potential new …
The Future of AI-Driven Drug Development Featured in Digital Health Insights
July 23, 2026 — GATC Health President Dr. Rahul Gupta is featured prominently throughout a new article published by Digital Health Insights…
GATC Health Experts Featured in Two High-Profile Panels at BIO International 2026
July 7, 2026 — GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development,…
GATC Health Showcases Digital Twin Innovations at Sanofi
June 25, 2026 — This month, GATC Health had the privilege of participating in a focused, high-level presentation at Sanofi’s Cambridge…
GATC Health Takes the Stage at the DIA Global Annual Meeting—Life Sciences’ Largest Event
June 24, 2026 — Last week at the DIA Global Annual Meeting in Philadelphia, GATC Health President Dr. Rahul Gupta joined an estee…
Science Behind GATC-1021 Featured in Physicians Weekly
June 19, 2026 — A new feature in Physician’s Weekly explores the clinical science behind the discovery of GATC-1021, a…
GATC Health Featured in The Dominion Post
June 18, 2026 — A recent article in The Dominion Post featured GATC Health’s Chief Business Officer, Tyrone Lam, and Senior …
GATC Health Featured on Citeline’s In Vivo Podcast: A “FICO Score” for Drug Development
June 17, 2026 — In the episode, titled “GATC Health’s Derisq AI, A FICO Score For Drug Development,” GATC Health Chief…